Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload

被引：9
作者：
Alavi, Samin [1 ]
Sadeghi, Elham [2 ]
Ashenagar, Azin [1 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Mofid Childrens Hosp, Pediat Congenital Hematol Disorders Res, Tehran 1546815514, Iran
[2] Shahid Beheshti Univ Med Sci, Mofid Childrens Hosp, Thalassemia Comprehens Ctr, Tehran, Iran
来源：
BLOOD RESEARCH | 2014年 / 49卷 / 01期
关键词：
D O I：
10.5045/br.2014.49.1.72
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 73
页数：3
相关论文
共 10 条
[1]   Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" β-thalassemia major patients [J].
Balocco, Manuela ;
Carrara, Paola ;
Pinto, Valeria ;
Forni, Gian Luca .
AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (06) :460-461
[2]   Prevalence of iron overload complications among patients with β-thalassemia major treated at Dubai Thalassemia Centre [J].
Belhoul, Khawla Mohammed ;
Bakir, Maisan Lateef ;
Kadhim, Ahmed Mohamed ;
Dewedar, Hany ElSayed ;
Eldin, Mohamed Salah ;
AlKhaja, Fatheya Abbas .
ANNALS OF SAUDI MEDICINE, 2013, 33 (01) :18-21
[3]  
Chhim Rebecca F, 2013, J Pediatr Pharmacol Ther, V18, P14, DOI 10.5863/1551-6776-18.1.14
[4]   Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major [J].
Farmaki, Kallistheni ;
Tzoumari, Ioanna ;
Pappa, Christina ;
Chouliaras, Giorgos ;
Berdoukas, Vasilios .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (03) :466-475
[5]   Combined iron chelation therapy [J].
Galanello, Renzo ;
Agus, Annalisa ;
Campus, Simona ;
Danjou, Fabrice ;
Giardina, Patricia J. ;
Grady, Robert W. .
COOLEY'S ANEMIA: NINTH SYMPOSIUM, 2010, 1202 :79-86
[6]   Management of transfusional iron overload differential properties and efficacy of iron chelating agents [J].
Kwiatkowski, Janet L. .
JOURNAL OF BLOOD MEDICINE, 2011, 2 :135-149
[7]   T2*magnetic resonance and myocardial iron in thalassemia [J].
Pennell, DJ .
COOLEY'S ANEMIA EIGHTH SYMPOSIUM, 2005, 1054 :373-378
[8]   Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone [J].
Porter, John B. ;
Wood, John ;
Olivieri, Nancy ;
Vichinsky, Elliott P. ;
Taher, Ali ;
Neufeld, Ellis ;
Giardina, Patricia ;
Thompson, Alexis ;
Moore, Blaine ;
Evans, Patricia ;
Kim, Hae-Young ;
Macklin, Eric A. ;
Trachtenberg, Felicia .
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2013, 15
[9]   Deferiprone (GPO-L-ONE®) monotherapy reduces iron overload in transfusion-dependent thalassemias: 1-year results from a multicenter prospective, single arm, open label, dose escalating phase III pediatric study (GPO-L-ONE; A001) from Thailand [J].
Viprakasit, Vip ;
Nuchprayoon, Issarang ;
Chuansumrit, Ampaiwan ;
Torcharus, Kitti ;
Pongtanakul, Bunchoo ;
Laothamatas, Jiraporn ;
Srichairatanakool, Somdet ;
Pooliam, Julaporn ;
Supajitkasem, Siriwat ;
Suriyaphol, Prapat ;
Tanphaichitr, Voravarn S. ;
Tuchinda, Soodsarkorn .
AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (04) :251-260
[10]   Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies [J].
Voskaridou, Ersi ;
Christoulas, Dimitrios ;
Terpos, Evangelos .
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (05) :654-656
1